Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen therapy and osteoporosis: principles & practice

M Notelovitz1

  • 1Women's Medical and Diagnostic Center, Gainesville, Florida, USA.

The American Journal of the Medical Sciences
|January 1, 1997
PubMed
Summary

Estrogen therapy significantly reduces fracture risk in postmenopausal women by maintaining bone density. Treatment requires individualized estrogen type, dose, and monitoring for optimal bone health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estradiol absorption from vaginal tablets in postmenopausal women.

Obstetrics and gynecology·2002
Same author

Effects of estrogen/androgen therapy on bone mineral density parameters.

The Journal of reproductive medicine·2001
Same author

Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17beta-estradiol.

Menopause (New York, N.Y.)·2000
Same author

The effect of site of application on the transcutaneous absorption of 17-beta estradiol from a transdermal delivery system (Climara).

Menopause (New York, N.Y.)·2000
Same author

Urogenital atrophy and low-dose vaginal estrogen therapy.

Menopause (New York, N.Y.)·2000
Same author

Initial 17beta-estradiol dose for treating vasomotor symptoms.

Obstetrics and gynecology·2000

Area of Science:

  • Endocrinology
  • Bone Biology
  • Gerontology

Background:

  • Postmenopausal osteoporosis is a significant health concern linked to estrogen deficiency.
  • Estrogen receptors are present in bone cells, regulating bone remodeling and calcium balance.
  • Estrogen deprivation critically impacts bone health and increases fracture risk.

Purpose of the Study:

  • To review the role of estrogen therapy in managing postmenopausal osteoporosis.
  • To highlight the efficacy of estrogen in reducing fracture risk.
  • To emphasize individualized treatment and monitoring strategies for estrogen therapy.

Main Methods:

  • Review of recent research on estrogen's effects on bone metabolism.
  • Analysis of data on fracture risk reduction with long-term estrogen use.

Related Experiment Videos

  • Discussion of factors influencing estrogen therapy efficacy.

    • Main Results:

    • Long-term estrogen therapy reduces hip fracture risk by 50-60% and vertebral deformities by 90%.
    • The protective effects of estrogen are dose-dependent and require adequate biologically active levels.
    • Estrogen therapy's bone-building capacity is enhanced by androgens, progestins, calcium, and exercise.

    Conclusions:

    • Estrogen therapy is highly effective in preventing fractures associated with postmenopausal osteoporosis.
    • Individualized estrogen therapy, including type, dose, and route, is crucial for optimal outcomes.
    • Monitoring bone density and biochemical markers ensures treatment efficacy and safety.